The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centres and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab

Rhodes, A., Borthwick, D., Sykes, R., Al-Sam, S. and Paradiso, A. (2004) The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centres and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab. American Journal of Clinical Pathology, 122. pp. 51-60. ISSN 0002-9173

Full text not available from this repository

Publisher's URL: http://dx.doi.org/10.1309/E9B5-5JYH-D84L-8Y17


Item Type:Article
Uncontrolled Keywords:cell line standards, cancer centres, automated image analysis, HER-2, neu, cell line standards, immunohistochemical assays, image analysis
Faculty/Department:Faculty of Health and Applied Sciences > Department of Biological, Biomedical and Analytical Sciences
ID Code:5796
Deposited By: R. Upload account
Deposited On:22 Jan 2010 15:10
Last Modified:03 Apr 2014 14:15

Request a change to this item

Copyright 2013 © UWE better together